Trulicity FDA Approval History , (Jan 28, 2021)
Recommended for: tirzepatide patients optimizing for cost, patients pursuing maximal fat oxidation support, patients with no specific methylation concerns
GLP-1 medications typically come in the form of tablets or a once-weekly self-injection with a tiny, virtually painless needle while NAD treatments only come as injections
Lifestyle changes have led to a surge in the incidence of obesity and type 2 diabetes, correlating to the increasing global prevalence of MASH (Fig.1)
This non-linear pricing mathematically proves that the active molecule itself is incredibly cheap to synthesize
GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them